By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tesaro, Inc. 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Tesaro, Inc. (TSRO) To Announce Third-Quarter 2014 Financial Results On November 5, 2014 10/23/2014 7:33:28 AM
Tesaro, Inc. (TSRO) Announces Closing Of $201.25 Million Public Offering Of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise Of The Underwriters' Option To Purchase Additional Notes 9/29/2014 11:55:48 AM
Tesaro, Inc. (TSRO) Announces Pricing Of $175 Million Of 3.00% Convertible Senior Notes Due 2021 9/24/2014 7:22:15 AM
Tesaro, Inc. (TSRO) Announces Offering Of $165 Million Of Convertible Senior Notes Due 2021 9/23/2014 7:34:11 AM
Opko Health, Inc. Licensee Tesaro, Inc. (TSRO) Submits New Drug Application for Rolapitant 9/8/2014 12:28:41 PM
Tesaro, Inc. (TSRO) Announces Submission Of Rolapitant New Drug Application (NDA) To FDA 9/8/2014 7:02:28 AM
Tesaro, Inc. (TSRO) Announces Participation At Several Upcoming Investor Conferences 8/21/2014 8:09:17 AM
Paradigm Announces Molecular Profiling Collaboration With Tesaro, Inc. (TSRO) 8/20/2014 8:13:00 AM
Tesaro, Inc. (TSRO) Announces Second-Quarter 2014 Operating Results 7/25/2014 7:32:09 AM
Tesaro, Inc. (TSRO) Appoints Mary Lynne Hedley, Ph.D., As Chief Operating Officer 7/25/2014 7:30:40 AM
12345
//-->